MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life-sciences research, today announced that the Abraxis Melamine Detection Kit has been validated for use on MDS Analytical Technologies’ SpectraMax® absorbance microplate readers with SoftMax® Pro 5 GxP analytical software, an industry-standard analysis software for FDA 21 CFR Part 11 compliance.